Fuji Pharma Co Ltd
TSE:4554
Fuji Pharma Co Ltd
TSE:4554
Price:
1 544 JPY
-2.83%
Market Closed
Updated:
May 14, 2024
EV/OCF
Enterprise Value to OCF
Enterprise Value to OCF
30.8
Current
25.1
Median
16.4
Industry
Higher
than median
Higher
than industry value
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
EV/OCF
=30.8
Enterprise Value
/
59.1B
Operating Cash Flow
1.9B
All Countries
| Market Cap | EV/OCF | ||||
|---|---|---|---|---|---|
| JP |
|
Fuji Pharma Co Ltd
TSE:4554
|
37.5B JPY | 30.8 | |
| JP |
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
776 550.9T JPY | -19 905 438.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
720.1B USD | 201.9 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
4.1T DKK | 43.5 | |
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 6 930.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
363.9B USD | 15.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
327.5B USD | 23.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
190.9B GBP | 248 | |
| CH |
|
Novartis AG
SIX:NOVN
|
182.1B CHF | 15.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
181.6B CHF | 12.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
160.6B USD | 25 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A
You don't have any saved screeners yet
